PFSI NOTIFICATION: PennyMac Financial Services, Inc. Investigated for Securities Misconduct Over Refinancing Issues, Investors with Losses Alerted to Contact BFA Law
newsfilecorp.com
Want to monitor PCRX?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor PCRXpacira pharmaceuticals, inc. (nasdaq: pcrx) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. the company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, exparel® (bupivacaine liposome injectable suspension), was commercially launched in the united states in april 2012.